Cargando…
Proteome analysis of NRF2 inhibition in melanoma reveals CD44 up‐regulation and increased apoptosis resistance upon vemurafenib treatment
Malignant melanoma is the deadliest form of skin cancer and NRF2 has been proposed as a main regulator of tumor cell malignancy. Still the mechanisms how NRF2 is contributing to melanoma progression are incompletely understood. Here we analyzed the effects of either NRF2 induction or depletion, and...
Autores principales: | Weitzenböck, Hans Peter, Gschwendtner, Anna, Wiesner, Christoph, Depke, Maren, Schmidt, Frank, Trautinger, Franz, Hengstschläger, Markus, Hundsberger, Harald, Mikula, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855890/ https://www.ncbi.nlm.nih.gov/pubmed/34951143 http://dx.doi.org/10.1002/cam4.4506 |
Ejemplares similares
-
Loss of SR-BI Down-Regulates MITF and Suppresses Extracellular Vesicle Release in Human Melanoma
por: Kinslechner, Katharina, et al.
Publicado: (2019) -
Generation of metastatic melanoma specific antibodies by affinity purification
por: Schütz, Birgit, et al.
Publicado: (2016) -
Concentration-Dependent Pro- and Antitumor Activities of Quercetin in Human Melanoma Spheroids: Comparative Analysis of 2D and 3D Cell Culture Models
por: Hundsberger, Harald, et al.
Publicado: (2021) -
Combined vemurafenib and fotemustine in patients with BRAF V600 melanoma progressing on vemurafenib
por: Queirolo, Paola, et al.
Publicado: (2016) -
Metastatic melanoma and vemurafenib: novel approaches
por: De Mello, Ramon Andrade
Publicado: (2012)